A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today Jul 16, 2025 16:00 JST On the morning of 15 July 2025, China Medical System Holdings Limited ("CMS" or the "Group") rang the...
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today Jul 16, 2025 15:00 HKT/SGT On the morning of 15 July 2025, China Medical System Holdings Limited ("CMS" or the "Group") rang the...
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange Jun 25, 2025 19:00 JST The board of directors of China Medical System Holdings Limited (the "Company", together with its subsidiaries
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange Jun 25, 2025 18:00 HKT/SGT The board of directors of China Medical System Holdings Limited (the "Company", together with its subsidiaries
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum Mar 21, 2025 23:00 HKT/SGT On March 17, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 annual...
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 Feb 14, 2025 21:00 JST In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China...
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 Feb 14, 2025 20:00 HKT/SGT In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China...
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 Jan 24, 2025 23:00 JST China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or...
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 Jan 24, 2025 23:00 HKT/SGT China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or...
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type Jan 09, 2025 09:00 JST China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or...
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type Jan 09, 2025 08:00 HKT/SGT China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or...
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China Dec 09, 2024 14:00 JST On 6 December, China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that...
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China Dec 09, 2024 13:00 HKT/SGT On 6 December, China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that...
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia Dec 02, 2024 22:30 JST China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or...
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia Dec 02, 2024 21:30 HKT/SGT China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or...
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area Oct 21, 2024 10:00 HKT/SGT China Medical System Holdings Limited (the "Group" or "CMS") is pleased to announce that on 18 October
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China Sep 24, 2024 22:00 JST China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or...